person · Reporting owner
Linthwaite Stephen Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | President & CEO | February 22, 2022 | February 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date February 22, 2022 · Filed February 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 326,334 |
Reported balance
After 2022-02-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-02-22 · Exercise / conversion · Acquired 7,813 · Balance 326,334 F1: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 333,216 |
Reported balance
After 2022-02-22 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-02-22 · Exercise / conversion · Acquired 6,882 · Balance 333,216 |
| Common StockSEC Table I · non-derivative | Direct | 340,938 |
Reported balance
After 2022-02-22 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-02-22 · Exercise / conversion · Acquired 7,722 · Balance 340,938 |
| Common StockSEC Table I · non-derivative | Direct | 328,473 |
Reported balance
After 2022-02-22 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2022-02-22 · Tax withholding · Disposed 12,465 · Balance 328,473 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,813 |
Reported balance
After 2022-02-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-22 · Exercise / conversion · Disposed 7,813 · Balance 7,813 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 27,528 |
Reported balance
After 2022-02-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-02-22 · Exercise / conversion · Disposed 6,882 · Balance 27,528 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 61,779 |
Reported balance
After 2022-02-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-02-22 · Exercise / conversion · Disposed 7,722 · Balance 61,779 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.
F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F5: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,691 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,917 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 9,791 | $7.91 | $77,446.81 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,513 Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 4,613 shares purchased on May 31, 2020 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| May 23, 2020 Filed May 26, 2020 13:30 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 310,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000059 · wf-form4_159049982349207.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: Common Stock · 310,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023. F2 · derivative.expiration_date: Restricted Stock Units vest over three years, with 1/2 of the total number of shares vesting on May 20, 2021 and 1/4 of the total number of shares vesting on each of May 20, 2022 and May 20, 2023. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,702 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,504 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,667 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 9,791 | $4.39 | $42,933.54 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,246 Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 22, 2020 22:29 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000057 · wf-form4_159018654328562.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 22:35 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 123,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000025 · wf-form4_158405250365992.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,555 Underlying: Common Stock · 123,555 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: Restricted Stock Units vest as to 1/4th of the underlying shares on February 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: Restricted Stock Units vest as to 1/4th of the underlying shares on February 20, 2021, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 27,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,584 Underlying: Common Stock · 27,528 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,316 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,417 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 21,124 | $3.75 | $79,215.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,593 Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 27,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 22:05 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000010 · wf-form4_158258193410027.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 01:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000093 · wf-form4_157447281456566.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,128 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 01:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000093 · wf-form4_157447281456566.xml · derivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,167 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 01:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 6,326 | $2.30 | $14,549.80 |
DisclosureSEC source: 0001162194-19-000093 · wf-form4_157447281456566.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,627 Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 01:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000093 · wf-form4_157447281456566.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 23, 2019 01:33 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000093 · wf-form4_157447281456566.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 23:58 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | PurchaseCommon Stock | 4,000 | $5.52 | $22,077.20 |
DisclosureSEC source: 0001162194-19-000084 · wf-form4_156695029893230.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,391 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000082 · wf-form4_156651089917875.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,940 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000082 · wf-form4_156651089917875.xml · derivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,917 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 6,326 | $6.04 | $38,209.04 |
DisclosureSEC source: 0001162194-19-000082 · wf-form4_156651089917875.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,391 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000082 · wf-form4_156651089917875.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000082 · wf-form4_156651089917875.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,461 shares purchased on May 31, 2019 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| May 20, 2019 Filed May 23, 2019 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000039 · wf-form4_155857327394512.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,752 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2019 Filed May 23, 2019 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000039 · wf-form4_155857327394512.xml · derivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,667 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2019 Filed May 23, 2019 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 6,326 | $12.14 | $76,797.64 |
DisclosureSEC source: 0001162194-19-000039 · wf-form4_155857327394512.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,694 Read SEC document |
| May 20, 2019 Filed May 23, 2019 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000039 · wf-form4_155857327394512.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2019 Filed May 23, 2019 01:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000039 · wf-form4_155857327394512.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000018 · wf-form4_155080143634005.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,564 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F5 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F5 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000018 · wf-form4_155080143634005.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,417 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F4 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 4,644 | $10.78 | $50,062.32 |
DisclosureSEC source: 0001162194-19-000018 · wf-form4_155080143634005.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,458 Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000018 · wf-form4_155080143634005.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 02:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000018 · wf-form4_155080143634005.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,235 shares purchased on November 30, 2018 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 02:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 110,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-19-000018 · wf-form4_155080143634005.xml · derivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,112 Underlying: Common Stock · 110,112 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: 12/48th of the total number of shares underlying the Restricted Stock Units granted will vest on February 20, 2020, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F3 · derivative.expiration_date: 12/48th of the total number of shares underlying the Restricted Stock Units granted will vest on February 20, 2020, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 02:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000118 · wf-form4_154285244329304.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,376 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 02:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000118 · wf-form4_154285244329304.xml · derivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,167 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 02:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 4,345 | $8.30 | $36,063.50 |
DisclosureSEC source: 0001162194-18-000118 · wf-form4_154285244329304.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,305 Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 02:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000118 · wf-form4_154285244329304.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 02:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000118 · wf-form4_154285244329304.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000096 · wf-form4_153497164208170.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,188 Underlying: Common Stock · 7,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.